REVENUES

3 Months Ended

Mar. 31, 2023

REVENUES

REVENUES

NOTE 4 – REVENUES

The following table summarizes the Company’s disaggregation of revenues:

	Three Months Ended March 31,
(U.S. dollars in thousands)	2023		2022
Pfizer	$	2,266	$	3,356
Brazil	$	2,800	$	5,454
Chiesi	$	—	$	218
Total revenues from selling goods	$	5,066	$	9,028
Revenues from license and R&D services	$	4,522	$	7,057